Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 112Lymphoma 66Lymphoma, Large B-Cell, Diffuse 50Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Lymphoma, Non-Hodgkin 29Lymphoma, Follicular 22Burkitt Lymphoma 22Multiple Myeloma 19Leukemia 16Hodgkin Disease 16Neoplasms 14Neoplasm Metastasis 13Lymphoma, B-Cell 13Lymphoma, Mantle-Cell 11Lymphoma, Large-Cell, Anaplastic 11Lymphoma, T-Cell 8Lymphoma, B-Cell, Marginal Zone 8Lymphoma, T-Cell, Peripheral 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Hematologic Neoplasms 5Waldenstrom Macroglobulinemia 4Recurrence 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, AIDS-Related 4Immunoblastic Lymphadenopathy 4Prostate Cancer Metastatic 3Primary Myelofibrosis 3Polycythemia Vera 3Plasmablastic Lymphoma 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3

Interventions

pembrolizumab 120Cisplatin 26Carboplatin 24Paclitaxel 21Docetaxel 17lenvatinib 15Pemetrexed 12Fluorouracil 12Saline Solution 11Capecitabine 10epacadostat 8Oxaliplatin 7Gemcitabine 7Leucovorin 5Cetuximab 5130-nm albumin-bound paclitaxel 5olaparib 4enzalutamide 4Irinotecan 4Bevacizumab 4Albumin-Bound Paclitaxel 4trifluridine tipiracil drug combination 3regorafenib 3Prednisone 3Dexamethasone 3Radiotherapy 2Ipilimumab 2Glucose 2Etoposide 2Doxorubicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Parkinson Disease 4, Autosomal Dominant Lewy Body × Prednisone × Clear all
NCT03834506 2025-07-18

KEYNOTE-921

Merck Sharp & Dohme LLC

Phase 3 Completed
1,030 enrolled 24 charts
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT03834519 2025-05-18

KEYLYNK-010

Merck Sharp & Dohme LLC

Phase 3 Completed
793 enrolled 23 charts
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT04907227 2024-07-12

KEYNOTE-921

Merck Sharp & Dohme LLC

Phase 3 Terminated
81 enrolled 19 charts
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡